CATALENT PHARMA SOLUTIONS

catalent-pharma-solutions-logo

Catalent Pharma Solutions, Inc. provides drug delivery technologies and outsourced development, manufacturing, and packaging services to the pharmaceutical, biotechnology, and consumer health industry worldwide. It operates in four segments: Development and Clinical Services, Oral Technologies, Sterile Technologies, and Packaging Services. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management for drugs and biologics in clinical tri... als. It also offers analytical chemical and cell-based testing and scientific services, respiratory products formulation and manufacturing, regulatory consulting, and biologics proprietary expression technology, and product development. The Oral Technologies segment provides formulation, development, and manufacturing services for the oral dose forms. Its oral drug delivery technologies include proprietary delivery technologies for drugs and consumer health products. This segment also offers formulation, development, and manufacturing services for conventional oral dose forms, including controlled release formulations, as well as immediate release tablets and capsules. The Sterile Technologies segment provides proprietary and traditional dose forms for separate routes of administration. It offers formulation and development for injectable drugs; and fills drugs or biologics into vials, pre-filled syringes, bags, and other sterile delivery formats. This segment's blow-fill-seal technology provides integrated dose form creation and filling of sterile liquids in a single process for respiratory, ophthalmic, and other routes of administration. The Packaging Services segment offers packaging services for pharmaceuticals, biologics, consumer health, and veterinary products, which include packaging drugs in blisters, bottles, pouches, and unit doses; and printed components, such as creating package inserts or folding cartons. The company is based in Somerset, New Jersey.

#People #Financial #Event #Website #More

CATALENT PHARMA SOLUTIONS

Industry:
Biotechnology Pharmaceutical Supply Chain Management

Founded:
2007-04-01

Address:
Somerset, New Jersey, United States

Country:
United States

Website Url:
http://www.catalent.com

Total Employee:
5001+

Status:
Active

Contact:
(877)587-1835

Email Addresses:
[email protected]

Total Funding:
550 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Sitelinks Search Box Euro Amazon



Current Advisors List

rolf-classon_image

Rolf Classon Member of the Board of Directors @ Catalent Pharma Solutions
Board_member
2014-08-01

james-quella_image

James Quella Member of the Board of Directors @ Catalent Pharma Solutions
Board_member
2009-12-01

ed-robinson_image

Ed Robinson Member, Biologics Advisory Board @ Catalent Pharma Solutions
Board_member
2015-04-01

melvin-booth_image

Melvin Booth Member of the Board of Directors @ Catalent Pharma Solutions
Board_member
2014-08-01

bruce-mcevoy_image

Bruce McEvoy Member of the Board of Directors @ Catalent Pharma Solutions
Board_member
2007-04-01

jack-stahl_image

Jack Stahl Board Member and Lead Director @ Catalent Pharma Solutions
Board_member
2014-08-01

j-carroll_image

J. Carroll Member of the Board of Directors @ Catalent Pharma Solutions
Board_member
2015-07-01

paul-clark_image

Paul Clark Member of the Board of Directors @ Catalent Pharma Solutions
Board_member

Current Employees Featured

paul-rudd_image

Paul Rudd
Paul Rudd Director CI and Technology @ Catalent Pharma Solutions
Director CI and Technology

steven-fasman_image

Steven Fasman
Steven Fasman Senior Vice President & General Counsel @ Catalent Pharma Solutions
Senior Vice President & General Counsel
2014-10-01

harshit-agarwal_image

Harshit Agarwal
Harshit Agarwal Scientist @ Catalent Pharma Solutions
Scientist
2021-08-01

laura-volpati_image

Laura Volpati
Laura Volpati Senior Project Manager @ Catalent Pharma Solutions
Senior Project Manager
2019-09-01

not_available_image

Robert Pauli Scherer
Robert Pauli Scherer Founder @ Catalent Pharma Solutions
Founder
2007-01-01

lisa-gerrizzo-megarr_image

Lisa Gerrizzo-Megarr
Lisa Gerrizzo-Megarr Senior Manager & Event Marketing @ Catalent Pharma Solutions
Senior Manager & Event Marketing
2014-02-01

marc-goemans_image

Marc Goemans
Marc Goemans VP, Business Development Cell & Gene Therapy Europe @ Catalent Pharma Solutions
VP, Business Development Cell & Gene Therapy Europe

emily-schirmer_image

Emily Schirmer
Emily Schirmer Senior Director Process Development @ Catalent Pharma Solutions
Senior Director Process Development
2020-01-01

not_available_image

Joseph Nawrocki
Joseph Nawrocki Director, Biophysical Characterization and Analysis @ Catalent Pharma Solutions
Director, Biophysical Characterization and Analysis

rachel-kravitz_image

Rachel Kravitz
Rachel Kravitz Principal Scientist, R&D @ Catalent Pharma Solutions
Principal Scientist, R&D
2021-07-01

Founder


not_available_image

Robert Pauli Scherer

Stock Details


Company's stock symbol is NYSE:CTLT

Acquisitions List

Date Company Article Price
2022-08-09 Metrics Contract Services Metrics Contract Services acquired by Catalent Pharma Solutions 475 M USD
2021-08-29 Bettera Brands Bettera Brands acquired by Catalent Pharma Solutions 1000 M USD
2021-02-23 Delphi Genetics Delphi Genetics acquired by Catalent Pharma Solutions N/A
2021-01-13 Acorda Therapeutics - INBRIJA Manufacturing Operations Acorda Therapeutics - INBRIJA Manufacturing Operations acquired by Catalent Pharma Solutions 80 M USD
2020-10-29 Skeletal Cell Therapy Support Skeletal Cell Therapy Support acquired by Catalent Pharma Solutions 12 M EUR
2020-02-03 MaSTherCell MaSTherCell acquired by Catalent Pharma Solutions 315 M USD
2019-04-14 Paragon Bioservices Paragon Bioservices acquired by Catalent Pharma Solutions 1.2 B USD
2018-07-03 Juniper Pharmaceuticals Juniper Pharmaceuticals acquired by Catalent Pharma Solutions 128 M USD
2017-09-19 Cook Pharmica, LLC Cook Pharmica, LLC acquired by Catalent Pharma Solutions N/A
2016-11-28 Accucaps Industries Accucaps Industries acquired by Catalent Pharma Solutions N/A

Newest Events participated

tides-oligonucleotide-and-peptide-therapeutics-2017_event_image Participated in TIDES: Oligonucleotide and Peptide Therapeutics 2017 on 2017-04-30 as sponsor

Official Site Inspections

http://www.catalent.com Semrush global rank: 166.42 K Semrush visits lastest month: 495.88 K

  • Host name: ec2-3-129-93-46.us-east-2.compute.amazonaws.com
  • IP address: 3.129.93.46
  • Location: Columbus United States
  • Latitude: 39.9653
  • Longitude: -83.0235
  • Metro Code: 535
  • Timezone: America/New_York
  • Postal: 43215

Loading ...

More informations about "Catalent Pharma Solutions"

About Us - Catalent

CATALENT CAREERS. DRUG DELIVERY INSTITUTE. INVESTORS. HIGH BUSINESS STANDARDS. As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full โ€ฆSee details»

Catalent - Wikipedia

In 1996, Cardinal Health acquired PCI (Headquarters: Philadelphia, Pennsylvania). PCI (Packaging Coordinators Inc.) is a pharmaceutical contract packing service for commercial and clinical packaging. In 1998, Cardinal Health acquired R.P. Scherer Corporation (Headquarters: Troy, Michigan). Robert Pauli Scherer founded the R.P. Scherer Corporation to commercialize his innovation of softgelSee details»

Catalent Pharma Solutions - LinkedIn

Catalent Pharma Solutions | 274,435 followers on LinkedIn. more products. better treatments. reliably supplied. โ„ข | Catalent, Inc. is a leading global contract development and โ€ฆSee details»

Catalent Pharma Solutions - LinkedIn

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and ...See details»

Leading Global CDMO for Pharma & Biotech | Catalent

Catalent is the #1 CDMO partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people's lives.See details»

Catalent - Crunchbase Company Profile & Funding

Catalent provides process development and cGMP manufacturing for adeno-associated viral (AAV) vector-based therapeutic candidates for clinical trials. Dry Powder Inhalation: Catalent offers capsule filling of dry powders for inhalation, โ€ฆSee details»

Catalent - The Org

Catalent is a global leader in providing integrated services, superior delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health โ€ฆSee details»

About Catalent Pharma Solutions - Indeed

Mar 27, 2024 Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that โ€ฆSee details»

Who We Are | Catalent Careers

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide.See details»

Catalent Pharma Solutions Information - RocketReach

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better โ€ฆSee details»

Catalent Pharma Solutions Careers and Employment - Indeed

Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested โ€ฆSee details»

Novo completes $16.5bn takeover of Catalent | pharmaphorum

1 day ago Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate โ€ฆSee details»

Org Chart Catalent Pharma Solutions - The Official Board

Sep 30, 2024 The organizational chart of Catalent Pharma Solutions displays its 51 main executives including Alessandro Maselli, Matti Masanovich and David McErlane. Toggle โ€ฆSee details»

Catalent, Inc. - Novo Holdings Completes Acquisition of Catalent

Dec 18, 2024 Catalent to Strengthen its Leading Position as a Global Service Provider for the Pharma and Biotech Industry under Private Ownership Catalent, Inc. (โ€œCatalentโ€), a leader in โ€ฆSee details»

Corporate Responsibility - Catalent

CORPORATE RESPONSIBILITY. Our corporate responsibility (CR) strategy and commitments represent how we put our values into action to run our business and achieve our mission to โ€ฆSee details»

Why Join Us | Catalent Careers

As a global organization with over 45 locations around the world, our diverse team works together in support of our mission to help people live better, healthier lives. Browse open jobs and Join us!See details»

Careers - Catalent

Remarkable Careers Begin Here. Join the global drug development and delivery leader that puts patients at the center of our work every day. At Catalent, you are part of a growing โ€ฆSee details»

Careers at Catalent | Catalent jobs

Find Your Dream Job at Catalent. Regardless of your degree, Catalent is a great place to begin your career. Find jobs in fields like Scientific & laboratory, IT, Finance and more Remarkable โ€ฆSee details»

Novo Holdings Completes Acquisition of Catalent

Catalent and Novo Holdings announced the completion of the acquisition in an all-cash transaction valued at approximately $16.5 billion. ... Catalent, Inc. is a leading global contract โ€ฆSee details»

Novo Holdings Gets FTCโ€™s Go-Ahead for Contentious $16.5B โ€ฆ

Dec 16, 2024 Despite stiff contention from industry, lawmakers and public-interest groups, the U.S. Federal Trade Commission on Saturday gave the greenlight to Novo Holdingsโ€™ proposed โ€ฆSee details»